In randomized controlled trials, There's two treatment options now regarded the normal of treatment in Guillain-Barré syndrome (GBS). These include things like possibly intravenous immunoglobulin (IVIG) or plasma exchange. IVIG is believed to act by its immune-modulating motion; even so, the precise